Conte J V
Division of Cardiac Surgery, Johns Hopkins Hospital, USA.
Md Med J. 1998 Nov;47(5):235-40.
Thoracic transplantation has been a clinical option for patients with end-stage heart and lung disease for three decades. Heart, lung, and combined heart-lung transplantations are no longer experimental procedures; they are a standard part of the treatment algorithm for selected patients with end-stage heart and lung disease. This article summarizes the current status of heart, lung, and heart-lung transplantations and provides an insight into the future of this field.
三十年来,胸段移植一直是终末期心肺疾病患者的一种临床选择。心脏、肺脏以及心肺联合移植已不再是实验性手术;它们是特定终末期心肺疾病患者治疗方案中的标准组成部分。本文总结了心脏、肺脏以及心肺联合移植的现状,并对该领域的未来进行了展望。